Trial intelligence / Profile preview

Dexamethasone for Postoperative Inflammation in Elderly Lumbar Spine Surgery

NCT04981093Completed

Sponsor
General Hospital of Ningxia Medical University
Start
Aug 2021
Primary completion
Jan 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of dexamethasone in post-operative inflammation (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Change of drainage fluid volume at Day 3 and Change of Inflammatory mediators in the drainage fluid at Day 3. Started Aug 2021; status: completed.

02

Drugs

dexamethasone
03

Conditions

post-operative inflammation

Beyond the preview

Go deeper on NCT04981093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04981093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call